Kevin Clancy is an owner and seasoned genomics and bioinformatics leader with over 20 years of experience translating scientific breakthroughs into operational, patient-ready programs across R&D, biotech and healthcare. He has repeatedly built high-impact capabilities from the ground up—most notably delivering a hospital-integrated translational genomics unit in under 18 months—and has led data, software and regulatory strategy that enabled medical device certifications and scalable NGS infrastructures. Kevin blends board-level strategic advising with hands-on execution in systems biology, synthetic biology, omics and AI-driven analytics, aligning investment decisions with measurable outcomes. He has managed cross-functional teams and global programs at organizations including Thermo Fisher, Synthetic Genomics, Invitae and Myriad, and is now consulting and serving on boards to help organizations operationalize precision medicine and cell therapy initiatives. An experimentally minded technologist with a PhD from Cambridge, he’s as comfortable designing LIMS and FAIR data pipelines as he is explaining technical risk to executives.
11 years of coding experience
24 years of employment as a software developer
PhD, Molecular neurobiology, PhD, Molecular neurobiology at University of Cambridge
BSc(Hons) Biochemistry, Biochemistry, BSc(Hons) Biochemistry, Biochemistry at Queen's University Belfast
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.